| Patterns and rates of exonic de novo mutations in autism spectrum disorders BM Neale, Y Kou, L Liu, A Ma’Ayan, KE Samocha, A Sabo, CF Lin, ... Nature 485 (7397), 242-245, 2012 | 2095 | 2012 |
| SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma JH Choe, PB Watchmaker, MS Simic, RD Gilbert, AW Li, NA Krasnow, ... Science translational medicine 13 (591), eabe7378, 2021 | 355 | 2021 |
| Current progress and open challenges for applying deep learning across the biosciences N Sapoval, A Aghazadeh, MG Nute, DA Antunes, A Balaji, R Baraniuk, ... Nature Communications 13 (1), 1728, 2022 | 257 | 2022 |
| IFNγ-dependent tissue-immune homeostasis is co-opted in the tumor microenvironment CJ Nirschl, M Suárez-Fariñas, B Izar, S Prakadan, R Dannenfelser, ... Cell 170 (1), 127-141. e15, 2017 | 161 | 2017 |
| Selective neuronal vulnerability in Alzheimer’s disease: a network-based analysis JP Roussarie, V Yao, P Rodriguez-Rodriguez, R Oughtred, J Rust, ... Neuron 107 (5), 821-835. e12, 2020 | 150 | 2020 |
| ESCAPE: database for integrating high-content published data collected from human and mouse embryonic stem cells H Xu, C Baroukh, R Dannenfelser, EY Chen, CM Tan, Y Kou, YE Kim, ... Database 2013, bat045, 2013 | 131 | 2013 |
| Discriminatory power of combinatorial antigen recognition in cancer T cell therapies R Dannenfelser, GM Allen, B VanderSluis, AK Koegel, S Levinson, ... Cell systems 11 (3), 215-228. e5, 2020 | 78 | 2020 |
| Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53 D Quigley, L Silwal-Pandit, R Dannenfelser, A Langerød, HKM Vollan, ... Molecular Cancer Research 13 (3), 493-501, 2015 | 75 | 2015 |
| JCoDA: a tool for detecting evolutionary selection SN Steinway, R Dannenfelser, CD Laucius, JE Hayes, S Nayak BMC bioinformatics 11, 1-9, 2010 | 59 | 2010 |
| Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity R Dannenfelser, M Nome, A Tahiri, J Ursini-Siegel, HKM Vollan, ... Oncotarget 8 (34), 57121, 2017 | 54 | 2017 |
| An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes A Jaiswal, A Verma, R Dannenfelser, M Melssen, I Tirosh, B Izar, TG Kim, ... Cancer Cell 40 (5), 524-544. e5, 2022 | 45 | 2022 |
| Network2Canvas: network visualization on a canvas with enrichment analysis CM Tan, EY Chen, R Dannenfelser, NR Clark, A Ma’ayan Bioinformatics 29 (15), 1872-1878, 2013 | 44 | 2013 |
| Genes2FANs: connecting genes through functional association networks R Dannenfelser, NR Clark, A Ma'ayan BMC bioinformatics 13, 1-13, 2012 | 43 | 2012 |
| Genes2WordCloud: a quick way to identify biological themes from gene lists and free text C Baroukh, SL Jenkins, R Dannenfelser, A Ma'Ayan Source code for biology and medicine 6, 1-5, 2011 | 37 | 2011 |
| Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab S Jabeen, M Zucknick, M Nome, R Dannenfelser, T Fleischer, S Kumar, ... Oncoimmunology 7 (11), e1457598, 2018 | 33 | 2018 |
| Sets2Networks: network inference from repeated observations of sets NR Clark, R Dannenfelser, CM Tan, ME Komosinski, A Ma'ayan BMC systems biology 6, 1-22, 2012 | 22 | 2012 |
| Recovering protein-protein and domain-domain interactions from aggregation of IP-MS proteomics of coregulator complexes AR Mazloom, R Dannenfelser, NR Clark, AV Grigoryan, KM Linder, ... PLoS computational biology 7 (12), e1002319, 2011 | 21 | 2011 |
| Bioinformatics approaches to profile the tumor microenvironment for immunotherapeutic discovery T Clancy, R Dannenfelser, O Troyanskaya, KJ Malmberg, E Hovig, ... Current pharmaceutical design 23 (32), 4716-4725, 2017 | 17 | 2017 |
| Joint embedding of biological networks for cross-species functional alignment L Li, R Dannenfelser, Y Zhu, N Hejduk, S Segarra, V Yao Bioinformatics 39 (9), btad529, 2023 | 12 | 2023 |
| Multi-antigen recognition circuits overcome challenges of specificity, heterogeneity, and durability in T cell therapy for glioblastoma JH Choe, PB Watchmaker, MS Simic, RD Gilbert, AW Li, NA Krasnow, ... bioRxiv, 2021.01. 07.425632, 2021 | 5 | 2021 |
Olga TroyanskayaPrinceton University and Flatiron Institute, Simons Foundation在 princeton.edu 的电子邮件经过验证
